1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome
- 8 March 2004
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 72 (4), 259-263
- https://doi.org/10.1111/j.0902-4441.2003.00210.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemiaLeukemia, 2003
- ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2003
- An Ile-568 to Asn Polymorphism Prevents Normal Trafficking and Function of the Human P2X7 ReceptorJournal of Biological Chemistry, 2003
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemiaBlood, 2002
- Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemiaThe Lancet, 2002
- Chronic lymphocytic leukaemia: one disease or two?Annals of Hematology, 2002
- A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular studyThe Lancet, 2002
- CD38 expression is an important prognostic marker in chronic lymphocytic leukaemiaLeukemia, 2002
- A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 ReceptorJournal of Biological Chemistry, 2001